As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
Humira prefilled syringe sits cold in the refrigerator door, a slim beige box wedged between orange juice and salad dressing, waiting for the next injection day. For tens of thousands of US patients, ...
Celltrion USA is offering an 80 mg dose of Yuflyma (adalimumab-aaty), a high-concentration (100mg/ml) and citrate-free formulation of Humira (adalimumab) biosimilar, in the United States. Yuflyma is ...
Cimzia and Humira are both FDA-approved biologics that treat inflammatory conditions by preventing the immune system from attacking healthy cells. While both medications can cause injection site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results